George Demetri
MD
Director, Sarcoma Center
👥Biography 个人简介
George Demetri has been instrumental in establishing the tumor-agnostic paradigm for NTRK fusion-positive cancers through his work on kinase inhibitor development. His expertise in sarcoma and rare tumors has contributed to cross-histology clinical trial design for TRK-targeted agents. He is a pioneer in molecular classification of rare cancers.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 George Demetri 的研究动态
Follow George Demetri's research updates
留下邮箱，当我们发布与 George Demetri（Dana-Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment